Pathogen Reduction System Market 2027 By Product Type, Type, Application, End User, and Geography | The Insight Partners

Pathogen Reduction System Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Semi-Automated Pathogen Reduction System, Fully-Automated Pathogen Reduction System); Type (Plasma Pathogen Reduction, Whole blood Pathogen Reduction, Platelets Pathogen Reduction); Application (Viruses , Bacteria, Parasites, White Blood Cells); End User (Hospitals , Ambulatory Surgical Center , Research Centers, Blood Banks, Others), and Geography

Report Code: TIPRE00015233 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Pathogen reduction systems are widely used to inactivate viruses and bacteria that may contaminate blood products. The pathogen reduction systems work on the principle of exposing the plasma to the ultraviolet rays in the presence of photosensitizer to act as a pathogen inactivator. The pathogen reduction systems are manufactured to withstand infectious pathogens of different genera. The inactivation strength of the photosensitizer varies from product to product. Primarily the products are for blood infection disease applications. The Pathogen Reduction Systems is an advanced product offering in the management of the blood transfusion and pathogen inactivation. Current pathogen reduction technologies in practice utilize nucleic acid-targeting methodology through ultraviolet light for destroying pathogens such as viruses, bacteria, protozoa, and others.

MARKET DYNAMICS

The increase in demand for plasma proteins, rising investment in innovation, and continuously increasing prevalence of infectious diseases will spur the growth of the market. Additionally, growing demand for blood components and blood in various surgeries and interventions coupled with high prevalence of the infectious disease will boost the market growth to significant extent over the forecast period. However, constantly rising product launch and product penetration and fair reimbursement issues may restrain the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Pathogen Reduction Systems Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of pathogen reduction systems market with detailed market segmentation by type, product type, application, end-users and geography. The global pathogen reduction systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pathogen reduction systems market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global pathogen reduction systems market is segmented on the type, product type, application, and end-users. Based on type, the global pathogen reduction systems market is segmented plasma pathogen reduction, platelets pathogen reduction, and whole blood pathogen reduction. Based on product type, the global pathogen reduction systems market is segmented semi-automated pathogen reduction system, and fully-automated pathogen reduction system. Based on application, the global pathogen reduction systems market is segmented into viruses, bacteria, parasites, and white blood cells. Based on end user, the global pathogen reduction systems market is segmented into hospitals, blood banks, ambulatory surgical center, research centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pathogen reduction systems market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pathogen reduction systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pathogen reduction systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pathogen reduction systems market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the pathogen reduction systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pathogen reduction systems market are anticipated to lucrative growth opportunities in the future with the rising demand for pathogen reduction systems market in the global market. Below mentioned is the list of few companies engaged in the pathogen reduction systems market.

The report also includes the profiles of key pathogen reduction systems market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   TERUMO BCT, INC.
  •   Cerus Corporation
  •   Macopharma
  •   Octapharma
  •   AngioDynamics, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pathogen Reduction System - By Product Type
1.3.2 Pathogen Reduction System - By Type
1.3.3 Pathogen Reduction System - By Application
1.3.4 Pathogen Reduction System - By End User
1.3.5 Pathogen Reduction System - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PATHOGEN REDUCTION SYSTEM LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PATHOGEN REDUCTION SYSTEM - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PATHOGEN REDUCTION SYSTEM - GLOBAL MARKET ANALYSIS
6.1. PATHOGEN REDUCTION SYSTEM - GLOBAL MARKET OVERVIEW
6.2. PATHOGEN REDUCTION SYSTEM - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PATHOGEN REDUCTION SYSTEM - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEMI-AUTOMATED PATHOGEN REDUCTION SYSTEM
7.3.1. Overview
7.3.2. Semi-Automated Pathogen Reduction System Market Forecast and Analysis
7.4. FULLY-AUTOMATED PATHOGEN REDUCTION SYSTEM
7.4.1. Overview
7.4.2. Fully-Automated Pathogen Reduction System Market Forecast and Analysis
8. PATHOGEN REDUCTION SYSTEM - REVENUE AND FORECASTS TO 2027 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. PLASMA PATHOGEN REDUCTION
8.3.1. Overview
8.3.2. Plasma Pathogen Reduction Market Forecast and Analysis
8.4. WHOLE BLOOD PATHOGEN REDUCTION
8.4.1. Overview
8.4.2. Whole blood Pathogen Reduction Market Forecast and Analysis
8.5. PLATELETS PATHOGEN REDUCTION
8.5.1. Overview
8.5.2. Platelets Pathogen Reduction Market Forecast and Analysis
9. PATHOGEN REDUCTION SYSTEM - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. VIRUSES
9.3.1. Overview
9.3.2. Viruses Market Forecast and Analysis
9.4. BACTERIA
9.4.1. Overview
9.4.2. Bacteria Market Forecast and Analysis
9.5. PARASITES
9.5.1. Overview
9.5.2. Parasites Market Forecast and Analysis
9.6. WHITE BLOOD CELLS
9.6.1. Overview
9.6.2. White Blood Cells Market Forecast and Analysis
10. PATHOGEN REDUCTION SYSTEM - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. AMBULATORY SURGICAL CENTER
10.4.1. Overview
10.4.2. Ambulatory Surgical Center Market Forecast and Analysis
10.5. RESEARCH CENTERS
10.5.1. Overview
10.5.2. Research Centers Market Forecast and Analysis
10.6. BLOOD BANKS
10.6.1. Overview
10.6.2. Blood Banks Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. PATHOGEN REDUCTION SYSTEM REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Pathogen Reduction System Overview
11.1.2 North America Pathogen Reduction System Forecasts and Analysis
11.1.3 North America Pathogen Reduction System Forecasts and Analysis - By Product Type
11.1.4 North America Pathogen Reduction System Forecasts and Analysis - By Type
11.1.5 North America Pathogen Reduction System Forecasts and Analysis - By Application
11.1.6 North America Pathogen Reduction System Forecasts and Analysis - By End User
11.1.7 North America Pathogen Reduction System Forecasts and Analysis - By Countries
11.1.7.1 United States Pathogen Reduction System
11.1.7.1.1 United States Pathogen Reduction System by Product Type
11.1.7.1.2 United States Pathogen Reduction System by Type
11.1.7.1.3 United States Pathogen Reduction System by Application
11.1.7.1.4 United States Pathogen Reduction System by End User
11.1.7.2 Canada Pathogen Reduction System
11.1.7.2.1 Canada Pathogen Reduction System by Product Type
11.1.7.2.2 Canada Pathogen Reduction System by Type
11.1.7.2.3 Canada Pathogen Reduction System by Application
11.1.7.2.4 Canada Pathogen Reduction System by End User
11.1.7.3 Mexico Pathogen Reduction System
11.1.7.3.1 Mexico Pathogen Reduction System by Product Type
11.1.7.3.2 Mexico Pathogen Reduction System by Type
11.1.7.3.3 Mexico Pathogen Reduction System by Application
11.1.7.3.4 Mexico Pathogen Reduction System by End User
11.2. EUROPE
11.2.1 Europe Pathogen Reduction System Overview
11.2.2 Europe Pathogen Reduction System Forecasts and Analysis
11.2.3 Europe Pathogen Reduction System Forecasts and Analysis - By Product Type
11.2.4 Europe Pathogen Reduction System Forecasts and Analysis - By Type
11.2.5 Europe Pathogen Reduction System Forecasts and Analysis - By Application
11.2.6 Europe Pathogen Reduction System Forecasts and Analysis - By End User
11.2.7 Europe Pathogen Reduction System Forecasts and Analysis - By Countries
11.2.7.1 Germany Pathogen Reduction System
11.2.7.1.1 Germany Pathogen Reduction System by Product Type
11.2.7.1.2 Germany Pathogen Reduction System by Type
11.2.7.1.3 Germany Pathogen Reduction System by Application
11.2.7.1.4 Germany Pathogen Reduction System by End User
11.2.7.2 France Pathogen Reduction System
11.2.7.2.1 France Pathogen Reduction System by Product Type
11.2.7.2.2 France Pathogen Reduction System by Type
11.2.7.2.3 France Pathogen Reduction System by Application
11.2.7.2.4 France Pathogen Reduction System by End User
11.2.7.3 Italy Pathogen Reduction System
11.2.7.3.1 Italy Pathogen Reduction System by Product Type
11.2.7.3.2 Italy Pathogen Reduction System by Type
11.2.7.3.3 Italy Pathogen Reduction System by Application
11.2.7.3.4 Italy Pathogen Reduction System by End User
11.2.7.4 Spain Pathogen Reduction System
11.2.7.4.1 Spain Pathogen Reduction System by Product Type
11.2.7.4.2 Spain Pathogen Reduction System by Type
11.2.7.4.3 Spain Pathogen Reduction System by Application
11.2.7.4.4 Spain Pathogen Reduction System by End User
11.2.7.5 United Kingdom Pathogen Reduction System
11.2.7.5.1 United Kingdom Pathogen Reduction System by Product Type
11.2.7.5.2 United Kingdom Pathogen Reduction System by Type
11.2.7.5.3 United Kingdom Pathogen Reduction System by Application
11.2.7.5.4 United Kingdom Pathogen Reduction System by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Pathogen Reduction System Overview
11.3.2 Asia-Pacific Pathogen Reduction System Forecasts and Analysis
11.3.3 Asia-Pacific Pathogen Reduction System Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Pathogen Reduction System Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Pathogen Reduction System Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Pathogen Reduction System Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Pathogen Reduction System Forecasts and Analysis - By Countries
11.3.7.1 Australia Pathogen Reduction System
11.3.7.1.1 Australia Pathogen Reduction System by Product Type
11.3.7.1.2 Australia Pathogen Reduction System by Type
11.3.7.1.3 Australia Pathogen Reduction System by Application
11.3.7.1.4 Australia Pathogen Reduction System by End User
11.3.7.2 China Pathogen Reduction System
11.3.7.2.1 China Pathogen Reduction System by Product Type
11.3.7.2.2 China Pathogen Reduction System by Type
11.3.7.2.3 China Pathogen Reduction System by Application
11.3.7.2.4 China Pathogen Reduction System by End User
11.3.7.3 India Pathogen Reduction System
11.3.7.3.1 India Pathogen Reduction System by Product Type
11.3.7.3.2 India Pathogen Reduction System by Type
11.3.7.3.3 India Pathogen Reduction System by Application
11.3.7.3.4 India Pathogen Reduction System by End User
11.3.7.4 Japan Pathogen Reduction System
11.3.7.4.1 Japan Pathogen Reduction System by Product Type
11.3.7.4.2 Japan Pathogen Reduction System by Type
11.3.7.4.3 Japan Pathogen Reduction System by Application
11.3.7.4.4 Japan Pathogen Reduction System by End User
11.3.7.5 South Korea Pathogen Reduction System
11.3.7.5.1 South Korea Pathogen Reduction System by Product Type
11.3.7.5.2 South Korea Pathogen Reduction System by Type
11.3.7.5.3 South Korea Pathogen Reduction System by Application
11.3.7.5.4 South Korea Pathogen Reduction System by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Pathogen Reduction System Overview
11.4.2 Middle East and Africa Pathogen Reduction System Forecasts and Analysis
11.4.3 Middle East and Africa Pathogen Reduction System Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Pathogen Reduction System Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Pathogen Reduction System Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Pathogen Reduction System Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Pathogen Reduction System Forecasts and Analysis - By Countries
11.4.7.1 South Africa Pathogen Reduction System
11.4.7.1.1 South Africa Pathogen Reduction System by Product Type
11.4.7.1.2 South Africa Pathogen Reduction System by Type
11.4.7.1.3 South Africa Pathogen Reduction System by Application
11.4.7.1.4 South Africa Pathogen Reduction System by End User
11.4.7.2 Saudi Arabia Pathogen Reduction System
11.4.7.2.1 Saudi Arabia Pathogen Reduction System by Product Type
11.4.7.2.2 Saudi Arabia Pathogen Reduction System by Type
11.4.7.2.3 Saudi Arabia Pathogen Reduction System by Application
11.4.7.2.4 Saudi Arabia Pathogen Reduction System by End User
11.4.7.3 U.A.E Pathogen Reduction System
11.4.7.3.1 U.A.E Pathogen Reduction System by Product Type
11.4.7.3.2 U.A.E Pathogen Reduction System by Type
11.4.7.3.3 U.A.E Pathogen Reduction System by Application
11.4.7.3.4 U.A.E Pathogen Reduction System by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Pathogen Reduction System Overview
11.5.2 South and Central America Pathogen Reduction System Forecasts and Analysis
11.5.3 South and Central America Pathogen Reduction System Forecasts and Analysis - By Product Type
11.5.4 South and Central America Pathogen Reduction System Forecasts and Analysis - By Type
11.5.5 South and Central America Pathogen Reduction System Forecasts and Analysis - By Application
11.5.6 South and Central America Pathogen Reduction System Forecasts and Analysis - By End User
11.5.7 South and Central America Pathogen Reduction System Forecasts and Analysis - By Countries
11.5.7.1 Brazil Pathogen Reduction System
11.5.7.1.1 Brazil Pathogen Reduction System by Product Type
11.5.7.1.2 Brazil Pathogen Reduction System by Type
11.5.7.1.3 Brazil Pathogen Reduction System by Application
11.5.7.1.4 Brazil Pathogen Reduction System by End User
11.5.7.2 Argentina Pathogen Reduction System
11.5.7.2.1 Argentina Pathogen Reduction System by Product Type
11.5.7.2.2 Argentina Pathogen Reduction System by Type
11.5.7.2.3 Argentina Pathogen Reduction System by Application
11.5.7.2.4 Argentina Pathogen Reduction System by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PATHOGEN REDUCTION SYSTEM
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. PATHOGEN REDUCTION SYSTEM, KEY COMPANY PROFILES
14.1. TERUMO BCT, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. CERUS CORPORATION
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MACOPHARMA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. OCTAPHARMA
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ANGIODYNAMICS, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. TERUMO BCT, INC.
2. Cerus Corporation
3. Macopharma
4. Octapharma
5. AngioDynamics, Inc.
TIPRE00015233
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking